Hopes for British-made Covid vaccine by Christmas: Scientist leading Oxford University’s AstraZeneca backed trial says tens of millions of doses are ready to be rolled out by the end of the year
Tens of millions of British-made Covid-19 vaccines could be rolled out by December, it has been claimed.
Leader of the Oxford University and AstraZeneca-backed trial, Professor Andrew Pollard, says the team is ‘optimistic’ about getting the go-ahead for the ‘miracle’ vaccine by Christmas time.
He says their anti-viral would be ten times cheaper than Pfizer‘s product – which requires two injections several weeks apart and has to be stored at -78C.
The academic told the Sun their vaccine is stored at ‘fridge temperature’ and is very close to demonstrating ‘efficacy’ – which Pfizer proved on its own version on Monday.
People wearing face coverings queue for a coronavirus test at a centre in Liverpool
Healthcare providers will be able to source products from manufacturers like BioNTech/Pfizer and Astrazeneca/Oxford to sell to customers, but any such orders will be put at the ‘back of the queue’, according to government sources
Professor Pollard said: ‘We have been working tirelessly all year and can’t wait to see the results in the months ahead.
‘We are a small academic team in Oxford. It is a miracle that we have been able to conduct large scale trials in record speed.
‘Our partner AZ will deliver the vaccine on a not-for-profit basis.’
It comes after the Government said a further 462 people had died within 28 days of testing positive for Covid-19 as of Saturday.
As of 9am on Saturday, there had been a further 26,860 lab-confirmed cases of coronavirus in the UK, slightly down from 27,301 on Friday.